Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms

Lucas Bleicher; Ricardo Aparicio; Fabio M. Nunes; Leandro Martinez; Sandra M. Gomes Dias; Ana Carolina Migliorini Figueira; Maria Auxiliadora Morim Santos; Walter H. Venturelli; Rosangela Da Silva; Paulo Marcos Donate; Francisco A.R. Neves; Luiz A. Simeoni; John D. Baxter; Paul Webb; Munir S. Skaf; Igor Polikarpov

doi:10.1186/1472-6807-8-8

Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms

Lucas Bleicher, Ricardo Aparicio, Fabio M. Nunes, Leandro Martinez, Sandra M. Gomes Dias, Ana Carolina Migliorini Figueira, Maria Auxiliadora Morim Santos, Walter H. Venturelli, Rosangela Da Silva, Paulo Marcos Donate, Francisco A.R. Neves, Luiz A. Simeoni, John D. Baxter, Paul Webb, Munir S. Skaf, Igor Polikarpov

Research output: Contribution to journal › Article

40 Scopus citations

Abstract

Background. Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor

Original language	English (US)
Article number	8
Journal	BMC Structural Biology
Volume	8
DOIs	https://doi.org/10.1186/1472-6807-8-8
State	Published - 2008

ASJC Scopus subject areas

Structural Biology

Access to Document

10.1186/1472-6807-8-8

Fingerprint Dive into the research topics of 'Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms'. Together they form a unique fingerprint.

Cite this

Bleicher, L., Aparicio, R., Nunes, F. M., Martinez, L., Gomes Dias, S. M., Figueira, A. C. M., Santos, M. A. M., Venturelli, W. H., Da Silva, R., Donate, P. M., Neves, F. A. R., Simeoni, L. A., Baxter, J. D., Webb, P., Skaf, M. S., & Polikarpov, I. (2008). Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. BMC Structural Biology, 8, [8]. https://doi.org/10.1186/1472-6807-8-8

Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. / Bleicher, Lucas; Aparicio, Ricardo; Nunes, Fabio M.; Martinez, Leandro; Gomes Dias, Sandra M.; Figueira, Ana Carolina Migliorini; Santos, Maria Auxiliadora Morim; Venturelli, Walter H.; Da Silva, Rosangela; Donate, Paulo Marcos; Neves, Francisco A.R.; Simeoni, Luiz A.; Baxter, John D.; Webb, Paul; Skaf, Munir S.; Polikarpov, Igor.

In: BMC Structural Biology, Vol. 8, 8, 2008.

Research output: Contribution to journal › Article

Bleicher, Lucas ; Aparicio, Ricardo ; Nunes, Fabio M. ; Martinez, Leandro ; Gomes Dias, Sandra M. ; Figueira, Ana Carolina Migliorini ; Santos, Maria Auxiliadora Morim ; Venturelli, Walter H. ; Da Silva, Rosangela ; Donate, Paulo Marcos ; Neves, Francisco A.R. ; Simeoni, Luiz A. ; Baxter, John D. ; Webb, Paul ; Skaf, Munir S. ; Polikarpov, Igor. / Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. In: BMC Structural Biology. 2008 ; Vol. 8.

@article{4db3f4010a9e4f74bbdc930feac96982,

title = "Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms",

abstract = "Background. Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor",

author = "Lucas Bleicher and Ricardo Aparicio and Nunes, {Fabio M.} and Leandro Martinez and {Gomes Dias}, {Sandra M.} and Figueira, {Ana Carolina Migliorini} and Santos, {Maria Auxiliadora Morim} and Venturelli, {Walter H.} and {Da Silva}, Rosangela and Donate, {Paulo Marcos} and Neves, {Francisco A.R.} and Simeoni, {Luiz A.} and Baxter, {John D.} and Paul Webb and Skaf, {Munir S.} and Igor Polikarpov",

year = "2008",

doi = "10.1186/1472-6807-8-8",

language = "English (US)",

volume = "8",

journal = "BMC Structural Biology",

issn = "1472-6807",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms

AU - Bleicher, Lucas

AU - Aparicio, Ricardo

AU - Nunes, Fabio M.

AU - Martinez, Leandro

AU - Gomes Dias, Sandra M.

AU - Figueira, Ana Carolina Migliorini

AU - Santos, Maria Auxiliadora Morim

AU - Venturelli, Walter H.

AU - Da Silva, Rosangela

AU - Donate, Paulo Marcos

AU - Neves, Francisco A.R.

AU - Simeoni, Luiz A.

AU - Baxter, John D.

AU - Webb, Paul

AU - Skaf, Munir S.

AU - Polikarpov, Igor

PY - 2008

Y1 - 2008

N2 - Background. Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor

AB - Background. Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor

UR - http://www.scopus.com/inward/record.url?scp=43049106192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049106192&partnerID=8YFLogxK

U2 - 10.1186/1472-6807-8-8

DO - 10.1186/1472-6807-8-8

M3 - Article

C2 - 18237438

AN - SCOPUS:43049106192

VL - 8

JO - BMC Structural Biology

JF - BMC Structural Biology

SN - 1472-6807

M1 - 8

ER -